346 related articles for article (PubMed ID: 11678911)
1. Increased expression of CTLA-4 (CD152) by T and B lymphocytes in Wegener's granulomatosis.
Steiner K; Moosig F; Csernok E; Selleng K; Gross WL; Fleischer B; Bröker BM
Clin Exp Immunol; 2001 Oct; 126(1):143-50. PubMed ID: 11678911
[TBL] [Abstract][Full Text] [Related]
2. Enhanced expression of CTLA-4 (CD152) on CD4+ T cells in HIV infection.
Steiner K; Waase I; Rau T; Dietrich M; Fleischer B; Bröker BM
Clin Exp Immunol; 1999 Mar; 115(3):451-7. PubMed ID: 10193417
[TBL] [Abstract][Full Text] [Related]
3. Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells.
Moosig F; Csernok E; Wang G; Gross WL
Clin Exp Immunol; 1998 Oct; 114(1):113-8. PubMed ID: 9764612
[TBL] [Abstract][Full Text] [Related]
4. Expression of the costimulator molecules, CD80, CD86, CD28, and CD152 on lymphocytes from neonates and young children.
Elliott SR; Macardle PJ; Roberton DM; Zola H
Hum Immunol; 1999 Nov; 60(11):1039-48. PubMed ID: 10600000
[TBL] [Abstract][Full Text] [Related]
5. Costimulatory molecules in human periodontal disease tissues.
Gemmell E; McHugh GB; Grieco DA; Seymour GJ
J Periodontal Res; 2001 Apr; 36(2):92-100. PubMed ID: 11327084
[TBL] [Abstract][Full Text] [Related]
6. Chimeric co-stimulatory molecules that selectively act through CD28 or CTLA-4 on human T cells.
Lazetic S; Leong SR; Chang JC; Ong R; Dawes G; Punnonen J
J Biol Chem; 2002 Oct; 277(41):38660-8. PubMed ID: 12167647
[TBL] [Abstract][Full Text] [Related]
7. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK
J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116
[TBL] [Abstract][Full Text] [Related]
8. CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production.
Freeman GJ; Lombard DB; Gimmi CD; Brod SA; Lee K; Laning JC; Hafler DA; Dorf ME; Gray GS; Reiser H
J Immunol; 1992 Dec; 149(12):3795-801. PubMed ID: 1281186
[TBL] [Abstract][Full Text] [Related]
9. Th1 and Th2 CD4+ T cells and Tc1 and Tc2 CD8+ T cells of patients with Wegener's granulomatosis.
Ohta N; Fukase S; Fuse T; Aoyagi M
J Laryngol Otol; 2002 Aug; 116(8):605-9. PubMed ID: 12389688
[TBL] [Abstract][Full Text] [Related]
10. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation.
Dahlén E; Hedlund G; Dawe K
J Immunol; 2000 Mar; 164(5):2444-56. PubMed ID: 10679081
[TBL] [Abstract][Full Text] [Related]
11. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
[TBL] [Abstract][Full Text] [Related]
12. [Regulation of T-cell activation by CD28 and CTLA-4].
Nagel T; Kalden JR; Manger B
Med Klin (Munich); 1998 Oct; 93(10):592-7. PubMed ID: 9849050
[TBL] [Abstract][Full Text] [Related]
13. Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation.
Vandenborre K; Van Gool SW; Kasran A; Ceuppens JL; Boogaerts MA; Vandenberghe P
Immunology; 1999 Nov; 98(3):413-21. PubMed ID: 10583602
[TBL] [Abstract][Full Text] [Related]
14. CTLA-4 is a second receptor for the B cell activation antigen B7.
Linsley PS; Brady W; Urnes M; Grosmaire LS; Damle NK; Ledbetter JA
J Exp Med; 1991 Sep; 174(3):561-9. PubMed ID: 1714933
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of costimulatory molecules in chronic inflammatory periodontal disease tissue.
Orima K; Yamazaki K; Aoyagi T; Hara K
Clin Exp Immunol; 1999 Jan; 115(1):153-60. PubMed ID: 9933436
[TBL] [Abstract][Full Text] [Related]
16. Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis.
Komocsi A; Lamprecht P; Csernok E; Mueller A; Holl-Ulrich K; Seitzer U; Moosig F; Schnabel A; Gross WL
Am J Pathol; 2002 May; 160(5):1717-24. PubMed ID: 12000723
[TBL] [Abstract][Full Text] [Related]
17. Activated T cells can induce high levels of CTLA-4 expression on B cells.
Kuiper HM; Brouwer M; Linsley PS; van Lier RA
J Immunol; 1995 Aug; 155(4):1776-83. PubMed ID: 7543532
[TBL] [Abstract][Full Text] [Related]
18. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN
Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic T lymphocyte-associated antigen-4-Ig (CTLA-4-Ig) suppresses Staphylococcus aureus-induced CD80, CD86, and pro-inflammatory cytokine expression in human B cells.
Liu PC; Ssu CT; Tsao YP; Liou TL; Tsai CY; Chou CT; Chen MH; Leu CM
Arthritis Res Ther; 2020 Mar; 22(1):64. PubMed ID: 32228715
[TBL] [Abstract][Full Text] [Related]
20. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression.
Carreno BM; Bennett F; Chau TA; Ling V; Luxenberg D; Jussif J; Baroja ML; Madrenas J
J Immunol; 2000 Aug; 165(3):1352-6. PubMed ID: 10903737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
